News Release

New research offers a minimally invasive approach to deep brain stimulation

Shuo Chen awarded Science & PINS Prize for Neuromodulation

Grant and Award Announcement

American Association for the Advancement of Science (AAAS)

Washington, D.C. - Shuo Chen is the 2019 grand prize winner of the Science & PINS Prize for Neuromodulation, for developing a less invasive technique to precisely control the activity of neurons nestled deep in the brain. The findings, described in his prize-winning essay, "Optical modulation goes deep in the brain," could help usher in the next-generation of noninvasive brain stimulation technologies.

"Noninvasive, remote manipulation of deep brain activity stands at the frontier of neuroscience, and has great potential to be used in medical applications," said Chen. "Such technologies are urgently needed, considering that one third of people have reported mental disorders at some time in their life."

It is expected that in the next 10 years alone, the number of patients affected by a neurological disorder will reach 1.1 billion worldwide, yet safe and effective treatments for such diseases are lacking. Deep brain stimulation (DBS) has proved to be one of the most effective therapies to date for conditions like Parkinson's disease and obsessive-compulsive disorder.

DBS requires implantation of electrodes in hard-to-reach areas of the brain to electrically stimulate the neurons thought to be involved in the underlying illness. In addition to the procedure involving surgical and follow-up costs that can reach up to $35,000, the electrical stimulation used can fail to reach the intended neuron targets, and implantation is risky.

In search of a more precise and minimally invasive solution, Chen, currently a postdoctoral fellow at the University of California Berkeley, turned to optogenetics - the use of light to control neurons. He shifted the existing optogenetic technology into the near-infrared (NIR) wavelength, which is recognized for its tissue-penetrating capability, in contrast to the highly scattered and absorbed blue-green wavelengths.

He used nano-sized "light bulbs," called upconversion nanoparticles (UCNPs), as a way to convert invisible NIR light into visible blue-green light to activate close-by neurons. "Our approach transforms the tissue-penetrating NIR signal by a local convertor to a different signal - the visible light - capable of triggering ion channels for the modulation of neuronal activity," said Chen.

In his award-winning essay that will be published in the 2 August issue of Science, Chen demonstrated the potential of this method by stimulating various deep structures in the mouse brain by NIR delivered from outside of the skull. He successfully triggered neurons residing in an area of the brain suspected to be linked to major depression to release dopamine.

While the technique pioneered by Chen holds promise, two key challenges need to be addressed, he noted. "The first is improving the development of biocompatible energy convertors and noninvasive gene delivery technologies. The second is further optimizing the efficacy of neuron stimulation. When combined, truly noninvasive high-precision deep brain stimulation without surgical intervention may be realized," said Chen.

"Shuo Chen researches minimally invasive methods for deep brain stimulation to treat neurological disorders including Parkinson's disease. Dr. Chen used tissue-penetrating near-infrared light to stimulate nanoparticles implanted deep within a mouse brain. The nanoparticles emitted visible light, which activated targeted ion channels in neurons," said Science Translational Medicine editors Caitlin Czajka and Mattia Maroso. "The PINS Prize for Neuromodulation encourages such innovative research to drive translational developments that help patients."

"It is too soon to predict which technique will emerge at the forefront of next-generation noninvasive brain stimulation technology. However, we believe that achievements such as NIR upconversion optogenetics are rapidly unlocking numerous development routes and paving the way towards a bright therapeutic future," said Chen.

Established in 2016, the Science & PINS Prize for Neuromodulation is a highly competitive prize which honors scientists for their excellent contributions to neuromodulation research - awarded annually for outstanding research as described in a 1,500-word essay based on research performed in the past three years. The winner is awarded $25,000 and publication of his or her essay in Science. PINS provides financial support to allow the grand prize winner and finalist to attend the ceremony.

Chen and finalist Bozhi Tian will be recognized during an award ceremony that will be held at the beginning of the 2019 Annual Meeting of Chinese Neuromodulation Society & The 10th Neuromodulation Congress in Kunming, Yunnan Province of China on 31 August. A ceremony dinner will also be held the same day.

2019 Grand Prize Winner Shuo Chen, for his essay "Optical modulation goes deep in the brain." Chen received his undergraduate and master's degrees in chemical engineering from Tsinghua University and his Ph.D. in chemistry from the University of Tokyo. He then completed a JSPS postdoctoral fellowship in neuroscience at the RIKEN Center for Brain Science. He is now a Human Frontier Science Program postdoctoral fellow at UC Berkeley, where he is investigating the network and synaptic mechanisms of hippocampal replay sequences. His research interests include the development of minimally invasive methods to record and manipulate brain activity and how long-term memory is formed, stored, and recalled.

Finalist Bozhi Tian, for his essay “Nongenetic neural control with light.” Tian received his undergraduate and master’s degrees from Fudan University, and his Ph.D. degree from Harvard University. After postdoctoral training at Massachusetts Institute of Technology and Harvard Medical School, Tian started his lab in the Department of Chemistry at the University of Chicago in 2012. His current research involves bioelectronics, semiconductor-enabled probing of subcellular biophysics, and the chemical dynamics at soft-hard interfaces.

For the full text of finalist essays and for information about applying for next year's awards, see the Science Web site at


About PINS

Beijing PINS Medical Co. Ltd. is a company from China. Since the first Deep Brain Stimulation initiative of Tsinghua Univeristy in 2000, PINS Medical has gradually established a multinational corporation with headquarter based in Beijing and international business center in Singapore. As an innovative high-tech enterprise with focus on neuromodulation, a variety of clinical products have been developed to date, which include stimulators for deep brain, vagus nerve, spinal cord and sacral nerve stimulation therapies. PINS Medical devotes itself to providing cutting-edge treatments for patients who suffer from neurological disorders such as Parkinson's Disease, Epilepsy, OAB and Chronic Pain, etc.

As part of the "National Engineering Laboratory for Neuromodulation," PINS Medical works in close cooperation with Tsinghua University and the numerous affiliated clinical centers, becoming a center of attraction for a wide range of professional talents in areas of clinical research, innovative R&D and business management. Since 2008, PINS Medical has developed rapidly in becoming a leading brand in neuromodulation within the Chinese market, due to the success of its creative research platform that efficiency links basic research, R&D of novel products, clinical testing and market entry. With an outstanding reputation as a high-tech healthcare corporation, PINS Medical has a primary mission for providing innovative, high-quality products and services for patients to improve quality of life.

About AAAS

The American Association for the Advancement of Science (AAAS) is the world's largest general scientific society and publisher of the journal Science as well as Science Translational Medicine, Science Signaling, a digital, open-access journal, Science Advances, Science Immunology, and Science Robotics. AAAS was founded in 1848 and includes nearly 250 affiliated societies and academies of science, serving 10 million individuals. Science has the largest paid circulation of any peer-reviewed general science journal in the world. The non-profit AAAS is open to all and fulfills its mission to "advance science and serve society" through initiatives in science policy, international programs, science education, public engagement, and more. For the latest research news, log onto EurekAlert!, the premier science-news Web site, a service of AAAS. See

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.